Cargando…
Giant cell tumor - distal end radius: Do we know the answer?
BACKGROUND: The distal end of the radius is one of the common sites of involvement in giant cell tumors (GCTs) with reportedly increased propensity of recurrence. The objective of the present analysis was to study the modalities of management of the different types of distal end radius GCTs so as to...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989138/ https://www.ncbi.nlm.nih.gov/pubmed/21139767 http://dx.doi.org/10.4103/0019-5413.32046 |
_version_ | 1782192329704079360 |
---|---|
author | Panchwagh, Yogesh Puri, Ajay Agarwal, Manish Anchan, Chetan Shah, Mandip |
author_facet | Panchwagh, Yogesh Puri, Ajay Agarwal, Manish Anchan, Chetan Shah, Mandip |
author_sort | Panchwagh, Yogesh |
collection | PubMed |
description | BACKGROUND: The distal end of the radius is one of the common sites of involvement in giant cell tumors (GCTs) with reportedly increased propensity of recurrence. The objective of the present analysis was to study the modalities of management of the different types of distal end radius GCTs so as to minimize the recurrence rates and retain adequate function. MATERIALS AND METHODS: Twenty-four patients of distal end radius GCTs treated between January 2000 and December 2004 were retrospectively reviewed. Nineteen cases were available for follow-up with an average follow-up of 37.5 months. There was one Campanacci Grade 1 lesion, nine Grade 2 and 14 Grade 3 lesions. Thirteen (54%) of these patients were treated elsewhere earlier and presented with recurrence. The operative procedures that were performed were: curettage and cementing (five), curettage and bone grafting (seven), excision and proximal fibular arthroplasty (two), excision and wrist arthrodesis (nine) and excision of soft tissue recurrence (one). RESULTS: Functional status was evaluated using Musculo Skeletal Tumor Society scoring system which averaged 78%. The recurrence rate was 32%. Complications included local recurrence (six), nonunion at the graft bone junction (one), infection (one), deformity (two), stiffness (two), subluxation (two) and bony metastasis (one). CONCLUSIONS: The majority of patients undergoing curettage were either Campanacci Grade 1 or 2. Patients undergoing curettage and reconstruction had a better functional result (82%) as compared to arthrodesis or fibular arthroplasty (69%). Previous intervention did not appear to increase the recurrence rates. Even though complications occur, judicious decision-making and an appropriate treatment plan can ensure a satisfactory outcome in the majority of cases. |
format | Text |
id | pubmed-2989138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29891382010-12-07 Giant cell tumor - distal end radius: Do we know the answer? Panchwagh, Yogesh Puri, Ajay Agarwal, Manish Anchan, Chetan Shah, Mandip Indian J Orthop Symposium - Giant Cell Tumor BACKGROUND: The distal end of the radius is one of the common sites of involvement in giant cell tumors (GCTs) with reportedly increased propensity of recurrence. The objective of the present analysis was to study the modalities of management of the different types of distal end radius GCTs so as to minimize the recurrence rates and retain adequate function. MATERIALS AND METHODS: Twenty-four patients of distal end radius GCTs treated between January 2000 and December 2004 were retrospectively reviewed. Nineteen cases were available for follow-up with an average follow-up of 37.5 months. There was one Campanacci Grade 1 lesion, nine Grade 2 and 14 Grade 3 lesions. Thirteen (54%) of these patients were treated elsewhere earlier and presented with recurrence. The operative procedures that were performed were: curettage and cementing (five), curettage and bone grafting (seven), excision and proximal fibular arthroplasty (two), excision and wrist arthrodesis (nine) and excision of soft tissue recurrence (one). RESULTS: Functional status was evaluated using Musculo Skeletal Tumor Society scoring system which averaged 78%. The recurrence rate was 32%. Complications included local recurrence (six), nonunion at the graft bone junction (one), infection (one), deformity (two), stiffness (two), subluxation (two) and bony metastasis (one). CONCLUSIONS: The majority of patients undergoing curettage were either Campanacci Grade 1 or 2. Patients undergoing curettage and reconstruction had a better functional result (82%) as compared to arthrodesis or fibular arthroplasty (69%). Previous intervention did not appear to increase the recurrence rates. Even though complications occur, judicious decision-making and an appropriate treatment plan can ensure a satisfactory outcome in the majority of cases. Medknow Publications 2007 /pmc/articles/PMC2989138/ /pubmed/21139767 http://dx.doi.org/10.4103/0019-5413.32046 Text en © Indian Journal of Orthopaedics http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Symposium - Giant Cell Tumor Panchwagh, Yogesh Puri, Ajay Agarwal, Manish Anchan, Chetan Shah, Mandip Giant cell tumor - distal end radius: Do we know the answer? |
title | Giant cell tumor - distal end radius: Do we know the answer? |
title_full | Giant cell tumor - distal end radius: Do we know the answer? |
title_fullStr | Giant cell tumor - distal end radius: Do we know the answer? |
title_full_unstemmed | Giant cell tumor - distal end radius: Do we know the answer? |
title_short | Giant cell tumor - distal end radius: Do we know the answer? |
title_sort | giant cell tumor - distal end radius: do we know the answer? |
topic | Symposium - Giant Cell Tumor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989138/ https://www.ncbi.nlm.nih.gov/pubmed/21139767 http://dx.doi.org/10.4103/0019-5413.32046 |
work_keys_str_mv | AT panchwaghyogesh giantcelltumordistalendradiusdoweknowtheanswer AT puriajay giantcelltumordistalendradiusdoweknowtheanswer AT agarwalmanish giantcelltumordistalendradiusdoweknowtheanswer AT anchanchetan giantcelltumordistalendradiusdoweknowtheanswer AT shahmandip giantcelltumordistalendradiusdoweknowtheanswer |